Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03 on Revenues of $11.6M

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03. Revenue for the quarter came in at $11.6 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Worthington Industries (WOR) Misses Q4 EPS by 9c